Annual Total Long Term Liabilities
$2.57 M
+$1.85 M+257.21%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual total long term liabilities is $2.57 million, with the most recent change of +$1.85 million (+257.21%) on December 31, 2022.
- During the last 3 years, NAVB annual total long term liabilities has risen by +$1.36 million (+112.24%).
- NAVB annual total long term liabilities is now -95.89% below its all-time high of $62.62 million, reached on December 31, 2015.
Performance
NAVB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$700.30 K
-$200.00-0.03%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly total long term liabilities is $700.30 thousand, with the most recent change of -$200.00 (-0.03%) on September 30, 2023.
- Over the past year, NAVB quarterly long term liabilities has dropped by -$200.00 (-0.03%).
- NAVB quarterly long term liabilities is now -98.89% below its all-time high of $63.07 million, reached on September 30, 2015.
Performance
NAVB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NAVB Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +257.2% | -0.0% |
3 y3 years | +112.2% | -0.0% |
5 y5 years | +287.1% | -0.0% |
NAVB Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +257.2% | -73.7% | at low |
5 y | 5-year | at high | +257.2% | -84.7% | at low |
alltime | all time | -95.9% | +2473.0% | -98.9% | +600.3% |
Navidea Biopharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $700.30 K(-0.0%) |
Jun 2023 | - | $700.50 K(-73.7%) |
Mar 2023 | - | $2.66 M(+3.6%) |
Dec 2022 | $2.57 M(+257.2%) | $2.57 M(+3.2%) |
Sep 2022 | - | $2.49 M(+75.2%) |
Jun 2022 | - | $1.42 M(+75.3%) |
Mar 2022 | - | $811.30 K(+12.6%) |
Dec 2021 | $720.30 K(-27.7%) | $720.30 K(-1.2%) |
Sep 2021 | - | $729.00 K(-11.2%) |
Jun 2021 | - | $820.50 K(-9.8%) |
Mar 2021 | - | $909.40 K(-8.7%) |
Dec 2020 | $996.00 K(-17.8%) | $996.00 K(-7.8%) |
Sep 2020 | - | $1.08 M(-76.4%) |
Jun 2020 | - | $4.58 M(+277.7%) |
Mar 2020 | - | $1.21 M(+0.1%) |
Dec 2019 | $1.21 M(-1.6%) | $1.21 M(-9.4%) |
Sep 2019 | - | $1.34 M(-2.8%) |
Jun 2019 | - | $1.38 M(-5.0%) |
Mar 2019 | - | $1.45 M(+17.6%) |
Dec 2018 | $1.23 M(+85.4%) | $1.23 M(-1.6%) |
Sep 2018 | - | $1.25 M(+0.6%) |
Jun 2018 | - | $1.24 M(-7.0%) |
Mar 2018 | - | $1.34 M(+101.3%) |
Dec 2017 | $664.70 K(-93.5%) | $664.70 K(-5.9%) |
Sep 2017 | - | $706.30 K(+6.1%) |
Jun 2017 | - | $665.90 K(+14.1%) |
Mar 2017 | - | $583.80 K(-94.3%) |
Dec 2016 | $10.27 M(-83.6%) | $10.27 M(-8.3%) |
Sep 2016 | - | $11.20 M(+9.8%) |
Jun 2016 | - | $10.20 M(-17.4%) |
Mar 2016 | - | $12.35 M(-80.3%) |
Dec 2015 | $62.62 M(+92.2%) | $62.62 M(-0.7%) |
Sep 2015 | - | $63.07 M(+3.0%) |
Jun 2015 | - | $61.23 M(+83.4%) |
Mar 2015 | - | $33.39 M(+2.5%) |
Dec 2014 | $32.57 M(-1.4%) | $32.57 M(-19.7%) |
Sep 2014 | - | $40.57 M(-1.7%) |
Jun 2014 | - | $41.27 M(-1.3%) |
Mar 2014 | - | $41.80 M(+26.5%) |
Dec 2013 | $33.04 M(+359.6%) | $33.04 M(-5.0%) |
Sep 2013 | - | $34.77 M(+23.2%) |
Jun 2013 | - | $28.23 M(+168.9%) |
Mar 2013 | - | $10.50 M(+46.1%) |
Dec 2012 | $7.19 M(+7.1%) | $7.19 M(+87.0%) |
Sep 2012 | - | $3.84 M(-14.3%) |
Jun 2012 | - | $4.48 M(-12.1%) |
Mar 2012 | - | $5.10 M(-24.0%) |
Dec 2011 | $6.71 M(+140.9%) | $6.71 M(+837.1%) |
Sep 2011 | - | $716.40 K(-22.4%) |
Jun 2011 | - | $923.10 K(-3.6%) |
Mar 2011 | - | $957.90 K(-65.6%) |
Dec 2010 | $2.79 M(-83.1%) | $2.79 M(+39.3%) |
Sep 2010 | - | $2.00 M(-7.3%) |
Jun 2010 | - | $2.16 M(-87.2%) |
Mar 2010 | - | $16.88 M(+2.4%) |
Dec 2009 | $16.48 M(+59.7%) | $16.48 M(-3.7%) |
Sep 2009 | - | $17.12 M(-51.4%) |
Jun 2009 | - | $35.24 M(+61.0%) |
Mar 2009 | - | $21.89 M(+112.1%) |
Dec 2008 | $10.32 M | $10.32 M(+48.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2008 | - | $6.95 M(+1.0%) |
Jun 2008 | - | $6.88 M(+7.9%) |
Mar 2008 | - | $6.37 M(-27.9%) |
Dec 2007 | $8.84 M(+79.5%) | $8.84 M(+299.4%) |
Sep 2007 | - | $2.21 M(-37.4%) |
Jun 2007 | - | $3.54 M(+3.1%) |
Mar 2007 | - | $3.43 M(-30.4%) |
Dec 2006 | $4.92 M(-18.7%) | $4.92 M(-23.9%) |
Sep 2006 | - | $6.46 M(+2.3%) |
Jun 2006 | - | $6.32 M(+2.3%) |
Mar 2006 | - | $6.17 M(+2.0%) |
Dec 2005 | $6.05 M(-26.1%) | $6.05 M(+1.7%) |
Sep 2005 | - | $5.95 M(+1.6%) |
Jun 2005 | - | $5.86 M(+1.8%) |
Mar 2005 | - | $5.75 M(-29.8%) |
Dec 2004 | $8.19 M(+1300.1%) | $8.19 M(+6082.7%) |
Sep 2004 | - | $132.50 K(-5.6%) |
Jun 2004 | - | $140.40 K(-35.3%) |
Mar 2004 | - | $217.10 K(-62.9%) |
Dec 2003 | $585.10 K(-50.0%) | $585.10 K(+102.6%) |
Sep 2003 | - | $288.80 K(-42.0%) |
Jun 2003 | - | $497.90 K(-27.4%) |
Mar 2003 | - | $685.90 K(-41.4%) |
Dec 2002 | $1.17 M(-40.0%) | $1.17 M(-19.0%) |
Sep 2002 | - | $1.44 M(-9.1%) |
Jun 2002 | - | $1.59 M(-10.6%) |
Mar 2002 | - | $1.78 M(-8.8%) |
Dec 2001 | $1.95 M(-12.7%) | $1.95 M(+20.1%) |
Sep 2001 | - | $1.62 M(-11.1%) |
Jun 2001 | - | $1.83 M(-10.0%) |
Mar 2001 | - | $2.03 M(-9.1%) |
Dec 2000 | $2.23 M(-48.2%) | $2.23 M(-8.3%) |
Sep 2000 | - | $2.44 M(-9.1%) |
Jun 2000 | - | $2.68 M(-6.1%) |
Mar 2000 | - | $2.86 M(+2755.3%) |
Dec 1999 | $4.31 M(+2669.1%) | - |
Jun 1999 | - | $100.00 K(0.0%) |
Mar 1999 | - | $100.00 K(-35.8%) |
Dec 1998 | $155.80 K(-92.5%) | $155.80 K(-96.7%) |
Sep 1998 | - | $4.70 M(+2.2%) |
Jun 1998 | - | $4.60 M(+4.5%) |
Mar 1998 | - | $4.40 M(+112.7%) |
Dec 1997 | $2.07 M(+106.9%) | $2.07 M(+3.4%) |
Sep 1997 | - | $2.00 M(+5.3%) |
Jun 1997 | - | $1.90 M(+46.2%) |
Mar 1997 | - | $1.30 M(+30.0%) |
Dec 1996 | $1.00 M(-9.1%) | $1.00 M(0.0%) |
Sep 1996 | - | $1.00 M(+66.7%) |
Jun 1996 | - | $600.00 K(0.0%) |
Mar 1996 | - | $600.00 K(-45.5%) |
Dec 1995 | $1.10 M(-8.3%) | $1.10 M(-8.3%) |
Sep 1995 | - | $1.20 M(+500.0%) |
Jun 1995 | - | $200.00 K(0.0%) |
Mar 1995 | - | $200.00 K(-83.3%) |
Dec 1994 | $1.20 M(+1100.0%) | $1.20 M(+200.0%) |
Sep 1994 | - | $400.00 K(0.0%) |
Jun 1994 | - | $400.00 K(+100.0%) |
Mar 1994 | - | $200.00 K(+100.0%) |
Dec 1993 | $100.00 K | $100.00 K(0.0%) |
Sep 1993 | - | $100.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual total long term liabilities year-on-year change?
- What is Navidea Biopharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly long term liabilities year-on-year change?
What is Navidea Biopharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of NAVB is $2.57 M
What is the all time high annual total long term liabilities for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total long term liabilities is $62.62 M
What is Navidea Biopharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, NAVB annual total long term liabilities has changed by +$1.85 M (+257.21%)
What is Navidea Biopharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of NAVB is $700.30 K
What is the all time high quarterly long term liabilities for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total long term liabilities is $63.07 M
What is Navidea Biopharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, NAVB quarterly total long term liabilities has changed by -$200.00 (-0.03%)